Oaktree Acquisition in its latest filing included additional disclosures in its proxy on the planned merger with telehealth platform Hims & Hers. The additions come in response to a shareholder lawsuit brought by New York firm WeissLaw.
While the SPAC said in the filing it believes the initial proxy complies fully with all laws, it was voluntarily making additional disclosures “to avoid nuisance, cost and distraction, and to preclude any efforts to delay the closing of the business combination.”
The shareholder vote is set for tomorrow, Jan. 19.
If approved, the combined company is expected to have an implied initial enterprise value of approximately $1.6 billion, and an estimated $330 million in cash after closing. Read more.
